Gindy, Marian

Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 298

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection

Espeseth, A. S., Cejas, P. J., Citron, M. P., Wang, D., DiStefano, D. J., Callahan, C., Donnell, G. O., Galli, J. D., Swoyer, R., Touch, S., et al. (2020) · npj Vaccines

Respiratory viral infections researchSARS-CoV-2 and COVID-19 Research

Cited by 190

Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death

Chang, S. C., Gopal, P., Lim, S., Wei, X., Chandramohan, A., Mangadu, R., Smith, J., Ng, S., Gindy, M., Phan, U., et al. (2022) · Cell Chemical Biology

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 31

Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death

Chang, S. C., Gopal, P., Lim, S., Wei, X., Chandramohan, A., Mangadu, R., Smith, J., Ng, S., Gindy, M., Phan, U., et al. (2022) · Cell chemical biology

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 31